-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cy5NBO97PrtQH+IYi1SOyl7Kee4MS7nBTcKz/iLY8jzt5AA0u8JRpXhOsh5CqMbo RyaNE22Ry6MIQr++pEChwA== 0001209191-10-036670.txt : 20100701 0001209191-10-036670.hdr.sgml : 20100701 20100701192428 ACCESSION NUMBER: 0001209191-10-036670 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100701 FILED AS OF DATE: 20100701 DATE AS OF CHANGE: 20100701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEHTA DILIP J MD PHD CENTRAL INDEX KEY: 0001225494 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28782 FILM NUMBER: 10932201 MAIL ADDRESS: STREET 1: 870 UNITED NATION PLAZA STREET 2: APT 16E CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9497886700 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 3 1 doc3.xml FORM 3 SUBMISSION X0203 3 2010-07-01 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001225494 MEHTA DILIP J MD PHD 157 TECHNOLOGY DRIVE IRVINE CA 92618 1 0 0 0 Common Stock $.001 Par Value 22000 D Stock Option (Right to Buy) 4.90 2013-09-12 Common Stock 5000 D Stock Option (Right to Buy) 6.05 2014-07-10 Common Stock 20000 D Stock Option (Right to Buy) 6.66 2015-01-03 Common Stock 20000 D Stock Option (Right to Buy) 4.26 2015-12-06 Common Stock 15000 D Stock Option (Right to Buy) 6.56 2017-02-20 Common Stock 20000 D Stock Option (Right to Buy) 6.09 2009-06-26 2019-06-26 Common Stock 10000 D 25% of the option shares vested on September 12, 2003. The remaining option shares vested in equal annual amounts over 3 years. The option shares were fully vested on July 1, 2010. The options shares vested in equal amounts every six months from July 10, 2004 over two years. The option shares were fully vested on July 1, 2010. 25% of the option shares vested on January 3, 2005. The remaining option shares vested in equal annual amounts over 3 years. The option shares were fully vested on July 1, 2010. 25% of the option shares vested on January 1, 2006. The remaining option shares vested in equal annual amounts every January 1st over three years. The option shares were fully vested on July 1, 2010. 25% of the option shares vested on February 20, 2007. The remaining option shares vested in equal annual amounts over 3 years. The option shares were fully vested on July 1, 2010. Shyam Kumaria on behalf of Dr. Mehta by Power of Attorney. /S/ Shyam Kumaria 2010-07-01 EX-24.3_337712 2 poa.txt POA DOCUMENT POWER OF ATTORNEY AUTHORIZATION I hereby authorize Shyam Kumaria or Rajesh Shrotriya, acting singly, to sign and file on my behalf any and all forms required by the Securities and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the reporting of beneficial ownership of equity securities of Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and of changes in such beneficial ownership, together with any and all amendments thereto. This authorization shall be effective on and after the date set forth below and shall continue in effect until I am no longer required to file such forms, unless earlier revoked by me in writing. I acknowledge that the persons authorized hereunder are not assuming, nor is the Company assuming, any of my responsibilities to comply with Section 16 of the Exchange Act. Dated as of this 18th day of June, 2010. /s/ Dilip J. Mehta Dilip J. Mehta, M.D., Ph.D. -----END PRIVACY-ENHANCED MESSAGE-----